Form 4 for KTTA Pasithea Therapeutics Corp.
Accepted 2022-11-28 00:00:00 ET · period of report 2022-11-23 · accession 0001213900-22-075490 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-11-28 | 2022-11-23+ | KTTA | Marques Tiago | CEO, Dir | A - Grant | $1.01 | +9,206 | 815.0K | +1% | +$9,320 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-25 | A | A | 2,000 | $1.03 | 819,206 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-23 | A | A | 1,206 | $1.02 | 817,206 | D | — | — | |
| 3 | Common | Common Stock | 2022-11-23 | A | A | 1,000 | $1.03 | 816,000 | D | — | — | |
| 4 | Common | Common Stock | 2022-11-23 | A | A | 5,000 | $1.00 | 815,000 | D | — | — |